US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Irbesartan Bulk Active Pharmaceutical Ingredient.

Reason CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.

Aurobindo Pharma Limited (Unit I) D-0127-2019
Class II · Moderate risk Terminated

Ortho-Novum 7/7/7

Reason Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.

Janssen Pharmaceuticals, Inc. NDC 50458-178-06 D-0218-2019
Class II · Moderate risk Terminated

Ortho-Novum 1/35

Reason Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.

Janssen Pharmaceuticals, Inc. NDC 50458-176-28 D-0217-2019
Class II · Moderate risk Terminated

Catapres .2

Reason Failed Dissolution Specifications: OOS resultsduring routine stability testing

Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0007-01 D-0128-2019
Class II · Moderate risk Terminated

children's allergy relief

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. D-0278-2019
Class II · Moderate risk Terminated

children's allergy

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. NDC 56062-106-08 D-0277-2019
Class II · Moderate risk Terminated

Children's 24 Hour Allergy

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. NDC 41250-106-08 D-0276-2019
Class II · Moderate risk Terminated

Hydromorphone

Reason Lack of assurance of sterility

Avella of Deer Valley, Inc. Store 38 D-0133-2019
Class II · Moderate risk Terminated

Fentanyl

Reason Lack of assurance of sterility

Avella of Deer Valley, Inc. Store 38 D-0132-2019
Class II · Moderate risk Terminated

Morphine

Reason Lack of assurance of sterility

Avella of Deer Valley, Inc. Store 38 D-0131-2019
Class II · Moderate risk Terminated

Metoprolol Succinate Extended Release Tablets

Reason Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.

Teva Pharmaceuticals USA NDC 62037-831-01 D-0129-2019
Class II · Moderate risk Terminated

Testosterone 87.5mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-187-01 D-0237-2019
Class II · Moderate risk Terminated

Testosterone 50mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-150-01 D-0236-2019
Class II · Moderate risk Terminated

Testosterone 37.5 mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-137-01 D-0235-2019
Class II · Moderate risk Terminated

Testosterone 25 mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC D-0234-2019
Class II · Moderate risk Terminated

Testosterone 200mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-120-01 D-0233-2019
Class II · Moderate risk Terminated

Testosterone 12.5mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-112-01 D-0232-2019
Class II · Moderate risk Terminated

Testosterone 100mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-110-01 D-0231-2019
Class II · Moderate risk Terminated

Estradiol 6 mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-006-01 D-0230-2019
Class II · Moderate risk Terminated

Estradiol 25mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-025-01 D-0229-2019
Class II · Moderate risk Terminated

Estradiol 18mg pellet

Reason Lack of Assurance of Sterility

Qualgen, LLC NDC 69761-018-01 D-0228-2019